NEW PUBLICATION – WHITE PAPER: Dose Optimization in Cancer Drug Development – Review and Outcome of a Multi-Stakeholder Workshop
The Cancer Drug Development Forum (CDDF) is pleased to announce the release of a White Paper developed following the multi-stakeholder workshop “Dose Optimization in Cancer Drug Development,” held on 3–4 April 2023 in Amsterdam, the Netherlands, as a hybrid event....
Upcoming ACT EU Multi-Stakeholder Platform Advisory Group in June
Upcoming ACT EU Multi-Stakeholder Platform Advisory Group in June The Multi-stakeholder Platform Advisory Group (MSP Advisory Group) forms part of the ACT EU multi-stakeholder platform (ACT EU MSP), which aims to provide regulators and stakeholders with a...
Key Takeaways CDDF Live Webinar series – Bayesian Framework: Bayesian Approaches in Oncology Drug Development: Introduction and Motivations
The Cancer Drug Development Forum (CDDF) held a live webinar on “Bayesian Approaches in Oncology Drug Development: Introduction and Motivations” on 14 May at 17:00 CET. Conducted by Purvi Prajapati (Eli Lilly) and Natasha Mulhemann (Cytel). The lectures were followed...